Quadrille Capital nomme trois nouveaux Partners
pour renforcer sa position de leader dans le financement des sociétés de croissance en Europe et aux États-Unis. Alejandra Duran Gil, Vianney Barre et Edouard Brunet rejoignent Jérôme Chevalier, Henri de Perignon, Brice Delome et Ed Colby comme partners de Quadrille Capital, pour accélérer son développement global dans les métiers de l’investissement dans les sociétés […]
Medwing has secured €44 millions Series C funding
MEDWING has enjoyed continued success since its inception in 2017 with more than 500,000 candidates & 5,500 medical employers registered on its platform in the UK and Germany. The additional capital will help the company to continue its journey to becoming the leading healthcare job marketplace in Europe. VP Vianney Barre, has commented: “The healthcare system […]
Swedish fintech Anyfin lands €30 million to help Europeans take control of their financial wellbeing
Anyfin provides smart tools to refinance existing consumer loans with improved interest rates. The Anyfin platform can assess user applications in a few seconds and can help customers save around 50% on the cost of their loan. Over the course of 2022, the company experienced fivefold growth and the mobile app has now been downloaded […]
Homa, la start-up française qui affole les compteurs dans le jeu vidéo mobile
La pépite parisienne a bouclé une nouvelle levée de fonds de 100 millions de dollars. Ses jeux ont déjà été téléchargés un milliard de fois. Après avoir misé sur l’hypercasual, Homa se diversifie en lançant des jeux de plus en plus variés. Elle vient d’en boucler un autre de 100 millions de dollars mené par les fonds […]
BigHat Biosciences Raises $75 Million in Series B Funding to Design Safer, More Effective Antibodies
BigHat Biosciences is a biotech company founded in 2019 designing safer, more effective next-generation antibody therapies for patients with the combination of machine learning and synthetic biology. The company is led by a team of experts spanning machine learning, molecular biology, drug development, and medicine. Considering the complexity and cost of drug development, the (bio)pharmaceutical […]